Shares of Clorox Co. CLX inched 0.66% higher to $162.89 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.26% to 5,942.47 ...
The same day, a cosplay of the character was posted by Facebook user Pervychu Alice [2] (shown below). On January 5th, YouTuber Bijaan Mike uploaded a video of himself reacting to Clorox-chan images, ...
Pfizer's vaccine for Clostridium difficile (C. US biotech Vedanta Biosciences has been awarded up to $76.9 million to develop VE303 for high-risk Clostridioides difficile (C. diff.) infection by ...
The EU has officially adopted USB-C as the common charging standard. EU consumers can now use a single USB-C charger for smartphones, tablets, cameras, headphones, gaming consoles, and other devices.
Pfizer advances second-generation C. diff vaccine with Phase 2 data expected in 2025. Analyst maintains cautious optimism as investor sentiment remains muted on vaccine efforts. Pfizer hosted a ...
Clostridioides difficile (C. diff) is a bacterial infection that commonly affects people with ulcerative colitis (UC). It can worsen symptoms and cause complications. It can also trigger a ...
The Clorox Company CLX stock has been trending up the charts in the past six months, recording a gain of 20.5%. This gain comfortably outpaces the broader Consumer Staples sector’s rise of 3.2% ...
Shares of Clorox Co. CLX inched 0.62% higher to $167.35 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.57% to 6,021.63 ...
Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.